Stomach fluid test could revolutionize gastric cancer diagnosis
NCT ID NCT07332104
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study explores a new way to diagnose gastric cancer by analyzing tiny particles called extracellular vesicles found in stomach fluid. Researchers will collect stomach fluid from 100 patients undergoing gastroscopy and use a special sensor to detect cancer-related changes. The goal is to see if this method can accurately identify gastric cancer, potentially offering a less invasive diagnostic option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a less invasive, more accurate way to diagnose gastric cancer early, potentially improving patient outcomes.
- What could go wrong
- This is an early-stage diagnostic study with only 100 participants. The new method may not prove more effective than current biopsy techniques, and results may not apply to all populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart drug home in on Hard-to-Treat GI cancers?
- Can an AI coach and simple exercises help cancer patients fight frailty?
- Electric acupoint therapy may speed digestion and ease pain after stomach cancer surgery
- New imaging tracer could spot hidden cancers and fibrosis in one scan
- New PET tracer aims to spot hidden cancer spread in the abdomen
- Triple attack on stomach cancer: radiation, chemo, and a smart antibody